Canaccord Genuity Group, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: CA1348011091
CAD
11.11
-0.09 (-0.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Canaccord Genuity Group, Inc. stock-summary
stock-summary
Canaccord Genuity Group, Inc.
Capital Markets
Canaccord Genuity Group Inc. is a Canada-based independent financial services company. The Company has operations in two principal segments of the securities industry: wealth management and capital markets. The Company's segments include Canaccord Genuity, Canaccord Genuity Wealth Management, and Corporate and Other. The Canaccord Genuity segment provides investment banking, research, and sales and trading services to corporate, institutional and government clients, as well as conducting principal trading activities in Canada, the United States, the United Kingdom and Europe, and the Asia-Pacific region. The Canaccord Genuity Wealth Management segment provides wealth management solutions and brokerage services to individual investors, private clients, charities and intermediaries. The Corporate and Other segment includes Pinnacle Correspondent Services, interest, foreign exchange revenue and expenses not allocable to Canaccord Genuity or Canaccord Genuity Wealth Management.
Company Coordinates stock-summary
Company Details
Suite 2200, 609 Granville Street , VANCOUVER BC : V7Y 1H2
stock-summary
Tel: 1 416 86760781 416 6875507
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.98%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. David Kassie
Executive Chairman of the Board
Mr. Daniel Daviau
President, Chief Executive Officer, Executive Director
Ms. Gillian Denham
Lead Independent Director
Mr. Charles Bralver
Independent Director
Mr. Michael Harris
Independent Director
Ms. Merri Jones
Independent Director
Mr. Terrence Lyons
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
448 Million
(Quarterly Results - Jun 2025)
Net Profit:
-17 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

CAD 1,213 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-5.59%

stock-summary
Price to Book

1.36